logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Giant Cell Arteritis

    FiltersReset Filters
    14 results

    • actemra

      (tocilizumab)
      Genentech, Inc.
      Usage: ACTEMRA (tocilizumab) is indicated for treating moderately to severely active rheumatoid arthritis, giant cell arteritis, systemic sclerosis-associated interstitial lung disease, polyarticular and systemic juvenile idiopathic arthritis, severe cytokine release syndrome from CAR T-cell therapy, and COVID-19 in hospitalized adults requiring respiratory support.

    • dexamethasone

      (Dexamethasone)
      Prasco Laboratories
      Usage: The drug is indicated for severe allergies, dermatologic and endocrine disorders, gastrointestinal and hematologic diseases, neurogenic conditions, neoplastic diseases, and various conditions across respiratory, ophthalmic, renal, and rheumatic diseases. It serves to manage symptoms or provide palliative care in specific cases.

    • dexamethasone

      (dexamethasone)
      Amneal Pharmaceuticals NY LLC
      Usage: This drug is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal issues, hematologic disorders, certain cancers, acute nervous system conditions, ocular inflammation, renal diseases, respiratory conditions, and as adjunctive therapy for rheumatic disorders. It addresses various severe and chronic health issues unresponsive to standard treatments.

    • methylprednisolone acetate

      (Methylprednisolone acetate)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone acetate injectable suspension is indicated for intramuscular, intra-articular, or intralesional administration to treat severe allergic conditions, dermatologic diseases, endocrine disorders, hematologic disorders, and various respiratory and rheumatic diseases, as well as for palliative care in neoplastic diseases and specific ophthalmic and renal conditions.

    • methylprednisolone acetate

      (METHYLPREDNISOLONE ACETATE)
      Sandoz Inc.
      Usage: Methylprednisolone acetate is indicated for use in allergic conditions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, and various other conditions. It can be administered intramuscularly, intra-articularly, or intralesionally for acute episodes in disorders like arthritis, dermatological lesions, and certain cancers.

    • methylprednisolone acetate

      (Methylprednisolone Acetate)
      Eugia US LLC
      Usage: Methylprednisolone acetate is indicated for intramuscular, intra-articular, and intralesional administration to treat severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal and hematologic diseases, and various inflammatory and autoimmune disorders, including arthritis and specific skin conditions, especially when oral therapy is not feasible.

    • methylprednisolone acetate

      (Methylprednisolone acetate)
      Amneal Pharmaceuticals NY LLC
      Usage: Methylprednisolone acetate injectable suspension is indicated for intramuscular, intra-articular, and intralesional administration to treat severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal diseases, hematologic disorders, rheumatic conditions, neoplastic diseases, and specific ophthalmic and respiratory diseases, among others.

    • methylprednisolone sodium succinate

      (Methylprednisolone)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone sodium succinate is indicated for intravenous or intramuscular administration in severe allergic conditions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neurological conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders, especially when oral therapy is not feasible.

    • methylprednisolone sodium succinate

      (METHYLPREDNISOLONE SODIUM SUCCINATE)
      Fresenius Kabi USA, LLC
      Usage: Methylprednisolone Sodium Succinate is indicated for intravenous or intramuscular use in severe allergic reactions, dermatologic and endocrine disorders, gastrointestinal diseases, hematologic conditions, neurological conditions, ophthalmic diseases, renal issues, respiratory diseases, and as adjunct therapy in rheumatic disorders and certain neoplastic diseases when oral therapy is not feasible.

    • prednisolone sodium phosphate

      (Prednisolone Sodium Phosphate)
      PAI Holdings, LLC
      Usage: Prednisolone sodium phosphate oral solution is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, acute multiple sclerosis exacerbations, ocular inflammation, respiratory diseases, rheumatic disorders, and specific miscellaneous conditions involving tuberculosis and organ rejection.